In 1987, prelude to embarking on its journey to be one of the most respectable pharmaceutical companies with the aim to have a state of art formulation unit in India, the vision of the group company had begun taking shape.
With continued research and scrutinizing various product options, Kesar Pharma finally established its first formulation unit in the year 2010 in Gujarat, India. During the process, Kesar crossed various milestones it had set for itself and became one of the most preferred contract manufacturing units by many multinational and leading Indian pharmaceutical brands for their various product options.
The present reputation of Kesar pharma is due to stringent standard it follows in its manufacturing processes by strictly complying with the CGMP, Good laboratory practices, regulatory compliances and following international guidelines for the development, manufacture and distribution of products across all formats.
Today, Kesar is proud to be a WHO (GMP) approved, CGMP 21 Countries approved manufacturing unit. In fact Kesar has added feather on the Gujarat’s cap and jewel on Indian crown for being an ethic based pharmaceutical manufacturing unit.
With it’s close to decade’s experience, Kesar has now formidable presence both in domestic as well as in the global market having footprints in 30 international markets. Kesar though considers itself a relatively new but a determined company who has chosen the path of achieving various milestones through its everyday operation.
Kesar Pharma is a committed entity that is manufacturing quality products at an affordable price through its 3 state of art manufacturing facilities in Gujarat, India. These facilities are having international approvals such as—WHO (GMP), CONGO (MOH), IVORY COAST, TAJIKISTAN, UGANDA (N.D.A), KENYA (P.P.B), NIGERIA (NAFDAC), YEMEN and GHANA (F.P.A).
Kesar facilities are also under inspection for approval from – PHILIPPINES, ZIMBABWE, AZERBAIJAN, ETHIOPIA (FMHACA), MALAWI (PPB), TANZANIA (TFDA), and EGYPT (for the year 2021-2022).
Kesar is also undertaking contract manufacturing from EU (GMP), new molecule development, new API development in its state of art R&D facility and C.R.O based at Ahmedabad, Gujarat, India.